论文部分内容阅读
氨茶碱作为解除支气管痉挛的药物,在世界各地广泛应用,其疗效肯定,但仍存在着争议,特别是用于治疗婴幼儿。近年来有些专家认为该药已过时,但有部分专家认为氨茶碱不但有解症、抗炎,而且有免疫调节及支气管保护作用。因此,在治疗哮喘病中,又有了新地位,但仍存在着一些副作用。现我们将氨茶碱在治疗婴幼儿哮喘中的临床体会总结如下。 1 一般资料 男12例,女8例,发病年龄<8个月6例,～1岁6例,～2岁4例,～3岁4例。
As a medicine to relieve bronchospasm, aminophylline is widely used all over the world and its efficacy is confirmed. However, there is still controversy, especially for the treatment of infants. In recent years, some experts believe that the drug is outdated, but some experts believe that not only aminophylline solution, anti-inflammatory, but also immune regulation and bronchial protection. Therefore, in the treatment of asthma, has a new status, but there are still some side effects. Now we aminophylline in the treatment of infant asthma clinical experience summarized below. 1 General information of 12 males and 8 females, the onset of age <8 months in 6 cases, ~ 1 year in 6 cases, ~ 2 years in 4 cases, ~ 3 years in 4 cases.